Tinnitus
Conditions
Keywords
Severe, Ongoing, Unilateral, present for more than 6 months
Brief summary
The objectives of this study are to evaluate the safety and efficacy of applying electrical stimulation on the promontorium (EPS) for the suppression of tinnitus in a sub-chronic stimulation regimen.
Interventions
DEVICENimbus Multifunctional Stimulator
A Multifunctional Stimulator (Nimbus by Newmedic, Hemodia) for clinical use. The stimulator is also dedicated for Electrical Promontory Stimulation (EPS)
Sponsors
EstimME Ltd.
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Total score on the Handicap Inventory (THI) of at least 40. 2. Visual scale over 5. 3. Tinnitus origin is peripheral (related to long term noise exposure, or to a sudden exposure to a very loud noise etc.) 4. Tinnitus is on-going; present for more than 50% of the time over the past 12 months. 5. Unilateral tinnitus 6. Tinnitus prevalent at least 12 months. 7. Willingness to abstain from part taking in other, non-study procedures indicated to lessen tinnitus and/or its perception. 8. Willing and able to refrain from engaging in activities or work involving loud noise exposure. 9. Male or females 18-60 years of age
Exclusion criteria
1. Prior history of sudden hearing loss and/or fluctuating hearing levels. 2. Tinnitus prevalent more than 3 years. 3. History of frequent middle ear infections 4. Patient under immunosuppressant therapy 5. Auditory nerve damage. 6. Vestibular Schwannoma 7. Cochlear implant. 8. Pregnant or lactating. 9. Developmental disability or cognitive impairment that would make it difficult for the subject to partake in the clinical study, including adequate comprehension of the informed consent form and ability to record the necessary measurements. 10. Involvement in litigation and/or a worker's compensation claim and/or receiving disability benefits related to tinnitus and/or hearing loss. 11. Not being physically or geographically capable of returning for scheduled follow-up visits. 12. Any physical, psychological, or emotional disorder that would interfere with the planned surgical operations 13. Mentally retarded, developmentally delayed or suffering from organic brain dysfunction.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Efficacy | 2 months | Study efficacy evaluations will be based on the analysis of pre and post procedure tinnitus severity characteristics (THI, MML, Pitch matching and VAS values). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Safety | 2 months | Safety evaluations will be based on the observation for the reporting of any adverse events occurring during the study and up to the 30 days follow-up visit Occurrence of adverse events. |
Countries
Israel
Outcome results
None listed